AIA Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-30,582
Closed -$1.72M 330
2024
Q4
$1.72M Sell
30,582
-149
-0.5% -$9.27K 0.04% 167
2024
Q3
$2.09M Buy
30,731
+2,179
+8% +$123K 0.05% 155
2024
Q2
$1.21M Buy
28,552
+3,620
+15% +$199K 0.04% 200
2024
Q1
$1.72M Sell
24,932
-4,005
-14% -$253K 0.06% 146
2023
Q4
$2.14M Buy
28,937
+733
+3% +$48K 0.09% 122
2023
Q3
$1.92M Buy
28,204
+4,436
+19% +$376K 0.09% 108
2023
Q2
$2.23M Sell
23,768
-327
-1% -$25.5K 0.11% 92
2023
Q1
$1.63M Buy
24,095
+13,045
+118% +$839K 0.09% 101
2022
Q4
$547K Sell
11,050
-7,427
-40% -$303K 0.03% 210
2022
Q3
$600K Buy
18,477
+647
+4% +$26.7K 0.04% 176
2022
Q2
$702K Sell
17,830
-2,955
-14% -$158K 0.04% 192
2022
Q1
$1.45M Sell
20,785
-17,462
-46% -$1.28M 0.06% 136
2021
Q4
$2.98M Buy
38,247
+2,655
+7% +$234K 0.14% 75
2021
Q3
$3.4M Buy
35,592
+5,787
+19% +$611K 0.19% 71
2021
Q2
$3.41M Buy
29,805
+2,125
+8% +$254K 0.23% 63
2021
Q1
$3.65M Buy
27,680
+19,262
+229% +$2.64M 0.53% 50
2020
Q4
$1.18M Buy
+8,418
New +$1.02M 0.14% 70

Other funds holding EXAS

AIA Group's EXAS Position: Q1 2025 in Review

AIA Group sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 30,582 shares — an estimated $1.72M sold.

AIA Group first reported a position in EXAS in Q4 2020 and held it in 17 quarters. The position peaked at $3.65M in Q1 2021. 556 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • AIA Group reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • AIA Group sold 30,582 Exact Sciences shares in Q1 2025, an estimated $1.72M.
  • AIA Group first reported a position in Exact Sciences in Q4 2020 and held it in 17 quarters.
  • AIA Group's Exact Sciences position peaked at $3.65M in Q1 2021.
  • 556 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on AIA Group's 13F filing for Q1 2025, filed 12 May 2025.